Endocrinology and Metabolism10.3803/enm.2017.32.1.620173216The SCAP/SREBP Pathway: A Mediator of Hepatic SteatosisYoung-Ah Moon,,
Gastroenterology10.1016/s0016-5085(11)64081-x20111405S-984-S-985Guggulsterone Inhibits LXRα Mediated SREBP-1c-Dependent Hepatic Steatosis Through PKC Dependent PathwayEun Ju Cho, Jung-Hwan Yoon,
Hong Kong Journal of Nephrology10.1016/j.hkjn.2015.08.0182015172S5Tangshen Formula Attenuates Hepatic Steatosis in db/db Mice by Mechanisms Involving AMPK/SREBP PathwayQin Kong, Ping Li,
Science-Business eXchange10.1038/scibx.2009.131920092341319-1319Sterol regulatory element binding protein (SREBP); SREBP chaperone (SCAP),,
Encyclopedia of Genetics, Genomics, Proteomics and Informatics10.1007/978-1-4020-6754-9_1509720081761-1761SCAP (SREBP cleavage-activating protein)
Scientific Reports10.1038/srep22640201661Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stabilityCaifeng Yan, Jinfeng Chen, Nuoqi Chen,,
Hepatology10.1053/jhep.2003.0902820033861529-1539Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppressionM Sekiya,
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2010.01275.x20101283-92Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1cP. Ferré, F. Foufelle,
Journal of Hepatology10.1016/s0168-8278(11)61264-6201154S4981262 GUGGULSTERONE INHIBITS LXRα MEDIATED SREBP-1C-DEPENDENT HEPATIC STEATOSIS THROUGH PKC DEPENDENT PATHWAYE.J. Cho, E.S. Jang, M.S. Kwak, S.J. Yu, J.-H. Lee, J.-H. Yoon,
Food & Function10.1039/c9fo00284g20191063410-3420Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathwayCong Zhang, Junjie Hu, Lei Sheng, Ming Yuan, Yong Wu, Liang Chen, Guihong Wang, Zhenpeng Qiu